{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:53:32Z","timestamp":1790027612072,"version":"4.0.1"},"reference-count":226,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.semcancer.2024.12.005","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T19:38:38Z","timestamp":1735328318000},"page":"25-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer"],"prefix":"10.1016","volume":"109","author":[{"given":"Chiara","family":"Corradi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Gentiluomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Adsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Sainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Riccardo","family":"Camisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Wlodarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tavano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Capurso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Campa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2024.12.005_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"Ca. Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2024.12.005_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca. Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2024.12.005_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: An overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2024.12.005_bib4","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.semcancer.2024.12.005_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib6","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ng.429","article-title":"Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer","volume":"41","author":"Amundadottir","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2024.12.005_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ng.522","article-title":"A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33","volume":"42","author":"Petersen","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2024.12.005_bib8","article-title":"Association between a polymorphic variant in the CDKN2B-AS1\/ANRIL gene and pancreatic cancer risk","author":"Giaccherini","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2024.12.005_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/jmedgenet-2020-106961","article-title":"Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction","volume":"58","author":"Galeotti","year":"2021","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.semcancer.2024.12.005_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/ng.3341","article-title":"Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer","volume":"47","author":"Childs","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2024.12.005_bib11","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ng.3052","article-title":"Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer","volume":"46","author":"Wolpin","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2024.12.005_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41467-018-02942-5","article-title":"Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer","volume":"9","author":"Klein","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2024.12.005_bib13","doi-asserted-by":"crossref","first-page":"66328","DOI":"10.18632\/oncotarget.11041","article-title":"Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2024.12.005_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.semcancer.2020.08.003","article-title":"Germline genetic variability in pancreatic cancer risk and prognosis","volume":"79","author":"Gentiluomo","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib15","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/ijc.33475","article-title":"Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility","volume":"148","author":"Corradi","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2024.12.005_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/jmg-2022-108910","article-title":"Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma","author":"Corradi","year":"2023","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.semcancer.2024.12.005_bib17","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/carcin\/bgab057","article-title":"Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma","volume":"42","author":"Pistoni","year":"2021","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2024.12.005_bib18","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.pan.2023.08.002","article-title":"Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasms","volume":"23","author":"Wood","year":"2023","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib19","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/01.MP.0000028647.98725.8B","article-title":"The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis","volume":"15","author":"Adsay","year":"2002","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/SLA.0000000000001173","article-title":"Members of Verona Consensus Meeting, Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting","volume":"263","author":"Adsay","year":"2016","journal-title":"Ann. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00000478-200407000-00001","article-title":"Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an \u201cintestinal\u201d pathway of carcinogenesis in the pancreas","volume":"28","author":"Adsay","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib22","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","article-title":"A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas","volume":"39","author":"Basturk","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib23","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJMra2309041","article-title":"Pancreatic Cysts","volume":"391","author":"Gonda","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2024.12.005_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41379-021-00902-x","article-title":"Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis","volume":"35","author":"Muraki","year":"2022","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/PAS.0000000000000357","article-title":"Clinicopathologic characteristics of 29 invasive carcinomas arising in 178 pancreatic mucinous cystic neoplasms with ovarian-type stroma: implications for management and prognosis","volume":"39","author":"Jang","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib26","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","article-title":"Early Detection of Pancreatic Cancer: Opportunities and Challenges","volume":"156","author":"Singhi","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib27","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MPA.0000000000001047","article-title":"Intraductal Papillary Mucinous Neoplasm of the Pancreas as the Main Focus for Early Detection of Pancreatic Adenocarcinoma","volume":"47","author":"Tanaka","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2024.12.005_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2011.04.003","article-title":"Intraductal papillary mucinous neoplasm","volume":"43","author":"Shi","year":"2012","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4251\/wjgo.v6.i9.311","article-title":"F. Colina-Ruizdelgado, Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas","volume":"6","author":"Castellano-Meg\u00edas","year":"2014","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cncr.10203","article-title":"Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients","volume":"94","author":"Adsay","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2024.12.005_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pan.2012.04.004","article-title":"International Association of Pancreatology, International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas","volume":"12","author":"Tanaka","year":"2012","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.soc.2009.11.002","article-title":"The management of intraductal papillary mucinous neoplasms of the pancreas","volume":"19","author":"Allen","year":"2010","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"10.1016\/j.semcancer.2024.12.005_bib33","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas","volume":"17","author":"Tanaka","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00423-017-1644-z","article-title":"Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas","volume":"403","author":"Tulla","year":"2018","journal-title":"Lange \u2019S. Arch. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib35","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.cell.2020.09.044","article-title":"Targeting KRAS(G12C): From Inhibitory Mechanism to Modulation of Antitumor Effects in Patients","volume":"183","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2024.12.005_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.pan.2012.08.001","article-title":"A comparative analysis of K-ras mutation and carcinoembryonic antigen in pancreatic cyst fluid","volume":"12","author":"Talar-Wojnarowska","year":"2012","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib37","doi-asserted-by":"crossref","first-page":"E1228","DOI":"10.1055\/s-0042-117216","article-title":"Endoscopic ultrasound-guided fine-needle aspiration plus KRAS and GNAS mutation in malignant intraductal papillary mucinous neoplasm of the pancreas","volume":"04","author":"Bournet","year":"2016","journal-title":"Endosc. Int. Open"},{"key":"10.1016\/j.semcancer.2024.12.005_bib38","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.gie.2008.07.033","article-title":"Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study","volume":"69","author":"Khalid","year":"2009","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.semcancer.2024.12.005_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/den.12710","article-title":"Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms","volume":"29","author":"Kadayifci","year":"2017","journal-title":"Dig. Endosc."},{"key":"10.1016\/j.semcancer.2024.12.005_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav4772","article-title":"A multimodality test to guide the management of patients with a pancreatic cyst","volume":"11","author":"Springer","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.semcancer.2024.12.005_bib41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jamcollsurg.2019.02.040","article-title":"Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential","volume":"228","author":"Maker","year":"2019","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib42","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/modpathol.2013.91","article-title":"Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts","volume":"26","author":"Nikiforova","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib43","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/j.gastro.2015.07.041","article-title":"A combination of molecular markers and clinical features improve the classification of pancreatic cysts","volume":"149","author":"Springer","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/cncy.21775","article-title":"Next-generation sequencing adds value to the preoperative diagnosis of pancreatic cysts","volume":"125","author":"Rosenbaum","year":"2017","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.gie.2015.06.047","article-title":"Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts","volume":"83","author":"Jones","year":"2016","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.semcancer.2024.12.005_bib46","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/15384047.2017.1281499","article-title":"Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer","volume":"18","author":"Yang","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.semcancer.2024.12.005_bib47","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1158\/1078-0432.CCR-14-0513","article-title":"Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts","volume":"20","author":"Singhi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2024.12.005_bib48","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1136\/gutjnl-2016-313586","article-title":"Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia","volume":"67","author":"Singhi","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2024.12.005_bib49","doi-asserted-by":"crossref","first-page":"92ra66","DOI":"10.1126\/scitranslmed.3002543","article-title":"Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development","volume":"3","author":"Wu","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.semcancer.2024.12.005_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.pan.2023.05.005","article-title":"Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis","author":"Pfl\u00fcger","year":"2023","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib51","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1002\/cam4.2340","article-title":"Genomic analysis of pancreatic juice DNA assesses malignant risk of intraductal papillary mucinous neoplasm of pancreas","volume":"8","author":"Mateos","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.semcancer.2024.12.005_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098718","article-title":"Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation","volume":"9","author":"Takano","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2024.12.005_bib53","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.10.029","article-title":"Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features","volume":"156","author":"Omori","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib54","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MPA.0000000000000258","article-title":"Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma","volume":"44","author":"Ideno","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2024.12.005_bib55","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00000658-199710000-00010","article-title":"Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas","volume":"226","author":"Z\u2019graggen","year":"1997","journal-title":"Ann. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib56","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.gastro.2019.08.032","article-title":"Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms","volume":"158","author":"Oyama","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib57","doi-asserted-by":"crossref","unstructured":"X.Y. Chang, Y. Wu, Y. Jiang, P.Y. Wang, J. Chen, RNF43 Mutations in IPMN Cases: A Potential Prognostic Factor, 2020 (2020). https:\/\/doi.org\/10.1155\/2020\/1457452.","DOI":"10.1155\/2020\/1457452"},{"key":"10.1016\/j.semcancer.2024.12.005_bib58","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00534-009-0105-7","article-title":"Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas","volume":"16","author":"Jang","year":"2009","journal-title":"J. Hepatobiliary. Pancreat. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib59","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00428-015-1751-6","article-title":"GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas","volume":"466","author":"Hosoda","year":"2015","journal-title":"Virchows Arch."},{"key":"10.1016\/j.semcancer.2024.12.005_bib60","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1136\/gutjnl-2015-311166","article-title":"Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms","volume":"66","author":"Yu","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2024.12.005_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/g3journal\/jkac314","article-title":"A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms","volume":"13","author":"Park","year":"2023","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.semcancer.2024.12.005_bib62","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/gutjnl-2020-321217","article-title":"Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions","volume":"70","author":"Fujikura","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2024.12.005_bib63","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MPA.0000000000000253","article-title":"Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas","volume":"44","author":"Kuboki","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2024.12.005_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2014.11.029","article-title":"GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma","volume":"220","author":"Tan","year":"2015","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib65","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00423-008-0285-7","article-title":"PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm\/carcinoma (IPMN\/C) of the pancreas","volume":"393","author":"Sch\u00f6nleben","year":"2008","journal-title":"Lange \u2019S. Arch. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/path.4344","article-title":"Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas","volume":"233","author":"Amato","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib67","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s11605-010-1411-8","article-title":"High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN)","volume":"15","author":"Lubezky","year":"2011","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib68","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pharmthera.2007.03.013","article-title":"Studies of the regulation and function of the Gs alpha gene Gnas using gene targeting technology","volume":"115","author":"Weinstein","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.semcancer.2024.12.005_bib69","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1186\/s40064-016-2847-4","article-title":"KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis","volume":"5","author":"Lee","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.semcancer.2024.12.005_bib70","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/gutjnl-2012-302823","article-title":"Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts","volume":"62","author":"Kanda","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2024.12.005_bib71","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1245\/s10434-013-3096-1","article-title":"Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas","volume":"20","author":"Molin","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib72","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/1541-7786.MCR-23-0199","article-title":"Oncogenic GNAS Uses PKA-Dependent and Independent Mechanisms to Induce Cell Proliferation in Human Pancreatic Ductal and Acinar Organoids","volume":"22","author":"Desai","year":"2024","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.semcancer.2024.12.005_bib73","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/onc.2015.294","article-title":"GNASR201H and KrasG12D cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm","volume":"35","author":"Taki","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2024.12.005_bib74","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.gastro.2016.04.034","article-title":"Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas","volume":"151","author":"Berger","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib75","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1101\/gad.235473.113","article-title":"The R-spondin\/Lgr5\/Rnf43 module: regulator of Wnt signal strength","volume":"28","author":"de Lau","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.semcancer.2024.12.005_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152453","article-title":"RNF43 frameshift mutations contribute to tumourigenesis in right-sided colon cancer","volume":"215","author":"Lai","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.semcancer.2024.12.005_bib77","doi-asserted-by":"crossref","first-page":"12649","DOI":"10.1073\/pnas.1307218110","article-title":"Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma","volume":"110","author":"Jiang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2024.12.005_bib78","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/modpathol.2014.98","article-title":"Clinicopathological significance of somatic RNF43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas","volume":"28","author":"Sakamoto","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib79","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ame2.12203","article-title":"Deficient Rnf43 potentiates hyperactive Kras-mediated pancreatic preneoplasia initiation and malignant transformation","volume":"5","author":"Zhou","year":"2022","journal-title":"Anim. Model. Exp. Med."},{"key":"10.1016\/j.semcancer.2024.12.005_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2012.11.016","article-title":"Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia","volume":"11","author":"Kanda","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib81","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jclinpath-2018-205216","article-title":"p16","volume":"71","author":"Serra","year":"2018","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib82","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gut.50.6.861","article-title":"Aberrant p16(INK4A) and DPC4\/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.","volume":"50","author":"Biankin","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2024.12.005_bib83","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00535-011-0482-y","article-title":"Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression","volume":"47","author":"Mohri","year":"2012","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib84","first-page":"21","article-title":"Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas","volume":"10","author":"Sasaki","year":"2003","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2024.12.005_bib85","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s005340200007","article-title":"p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas","volume":"9","author":"Wada","year":"2002","journal-title":"J. Hepatobiliary. Pancreat. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib86","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.cellbio.17.1.615","article-title":"Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer","volume":"17","author":"Katso","year":"2001","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib87","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.surg.2012.11.016","article-title":"MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas","volume":"153","author":"Lubezky","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.semcancer.2024.12.005_bib88","doi-asserted-by":"crossref","first-page":"74797","DOI":"10.18632\/oncotarget.11501","article-title":"Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression","volume":"7","author":"Durante","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2024.12.005_bib89","doi-asserted-by":"crossref","DOI":"10.1097\/MPA.0000000000002373","article-title":"Genetic assessment of IPMN for predicting concomitant pancreatic ductal adenocarcinoma","author":"Oi","year":"2024","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2024.12.005_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071475","article-title":"Intraductal Papillary Mucinous Neoplasms in Hereditary Cancer Syndromes","volume":"10","author":"Ardeshna","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.semcancer.2024.12.005_bib91","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/endrev\/bnz011","article-title":"Fibrous Dysplasia\/McCune-Albright Syndrome: A Rare, Mosaic Disease of G\u03b1 s Activation","volume":"41","author":"Boyce","year":"2020","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.semcancer.2024.12.005_bib92","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1210\/jc.2018-01022","article-title":"Clinical and Radiographic Gastrointestinal Abnormalities in McCune-Albright Syndrome","volume":"103","author":"Robinson","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2024.12.005_bib93","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/jamasurg.2014.535","article-title":"Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms:: GNAS-activating mutations in pancreatic carcinogenesis","volume":"149","author":"Parvanescu","year":"2014","journal-title":"JAMA Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib94","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1210\/jc.2013-1823","article-title":"Hepatobiliary and Pancreatic Neoplasms in Patients With McCune-Albright Syndrome","volume":"99","author":"Gaujoux","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcancer.2024.12.005_bib95","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00428-017-2086-2","article-title":"Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas","volume":"470","author":"Wood","year":"2017","journal-title":"Virchows Arch."},{"key":"10.1016\/j.semcancer.2024.12.005_bib96","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.7150\/jca.20750","article-title":"Pancreatic Cancer in Lynch Syndrome Patients","volume":"8","author":"Bujanda","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.semcancer.2024.12.005_bib97","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10689-018-00117-1","article-title":"Recent advances in Lynch syndrome","volume":"18","author":"Biller","year":"2019","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.semcancer.2024.12.005_bib98","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MPA.0000000000001201","article-title":"Pseudomyxoma Peritonei After a Total Pancreatectomy for Intraductal Papillary Mucinous Neoplasm With Colloid Carcinoma in Lynch Syndrome","volume":"48","author":"Hackeng","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2024.12.005_bib99","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.3748\/wjg.v21.i25.7916","article-title":"Intraductal papillary mucinous neoplasm of the ileal heterotopic pancreas in a patient with hereditary non-polyposis colorectal cancer: A case report","volume":"21","author":"Lee","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/PAS.0b013e3181882c3d","article-title":"Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome","volume":"33","author":"Sparr","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib101","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.3748\/wjg.v21.i9.2820","article-title":"V.G. Pillarisetty, Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome","volume":"21","author":"Flanagan","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib102","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1097\/MPA.0000000000002313","article-title":"Familial Intraductal Papillary Mucinous Neoplasm Associated With the Germline MSH6 Missense Variant and Progression of Pancreatic cancer","volume":"53","author":"Tezuka","year":"2024","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2024.12.005_bib103","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/jmg.34.12.1007","article-title":"Peutz-Jeghers syndrome","volume":"34","author":"Tomlinson","year":"1997","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.semcancer.2024.12.005_bib104","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0002-9440(10)63053-2","article-title":"STK11\/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas","volume":"159","author":"Sato","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.6004\/jnccn.2021.7107","article-title":"Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?","volume":"20","author":"Wang","year":"2022","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.semcancer.2024.12.005_bib106","first-page":"291","article-title":"G. Ucha\u0144ska, FAMMM syndrome: pathogenesis and management","volume":"30","author":"Czajkowski","year":"2004","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib107","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4251\/wjgo.v9.i9.390","article-title":"Pancreatic adenosquamous carcinoma and intraductal papillary mucinous neoplasm in a CDKN2A germline mutation carrier","volume":"9","author":"de Juan","year":"2017","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib108","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pan.2014.10.009","article-title":"Intraductal papillary mucinous neoplasm in a neonate with congenital hyperinsulinism and a de novo germline SKIL gene mutation","volume":"15","author":"Jiao","year":"2015","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib109","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1053\/j.gastro.2019.01.254","article-title":"Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms","volume":"156","author":"Skaro","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib110","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.22933","article-title":"Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms","volume":"3","author":"Capurso","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.semcancer.2024.12.005_bib111","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1158\/1055-9965.EPI-20-1581","article-title":"ABO Blood Group and Risk of Pancreatic Carcinogenesis in Intraductal Papillary Mucinous Neoplasms","volume":"30","author":"Hamada","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.semcancer.2024.12.005_bib112","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.pan.2021.12.012","article-title":"ABO blood group distribution and risk of malignancy in patients undergoing resection for intraductal papillary mucinous neoplasm (IPMN)","volume":"22","author":"Zelga","year":"2022","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib113","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11605-018-3795-9","article-title":"Blood Type as a Predictor of High-Grade Dysplasia and Associated Malignancy in Patients with Intraductal Papillary Mucinous Neoplasms","volume":"23","author":"Poruk","year":"2019","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib114","article-title":"A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy","author":"Gentiluomo","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2024.12.005_bib115","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/carcin\/bgac051","article-title":"A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs","volume":"43","author":"Giaccherini","year":"2022","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2024.12.005_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1172606","article-title":"Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression","volume":"13","author":"Gentiluomo","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib117","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1126\/science.aay3164","article-title":"The exposome and health: Where chemistry meets biology","volume":"367","author":"Vermeulen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2024.12.005_bib118","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.dld.2023.10.015","article-title":"Analysis of exposome and genetic variability suggests stress as a major contributor for development of pancreatic ductal adenocarcinoma","volume":"56","author":"Peduzzi","year":"2024","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.semcancer.2024.12.005_bib119","doi-asserted-by":"crossref","DOI":"10.1136\/jmedgenet-2019-106200","article-title":"Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer","author":"Lu","year":"2020","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.semcancer.2024.12.005_bib120","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae017","article-title":"Physical Activity, Sedentary Behavior, and Pancreatic Cancer Risk: A Mendelian Randomization Study","volume":"8","author":"Gentiluomo","year":"2024","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.semcancer.2024.12.005_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104020","article-title":"The PANcreatic Disease ReseArch (PANDoRA) consortium: ten years\u2019 experience of association studies to understand the genetic architecture of pancreatic cancer","author":"Campa","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib122","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ajg.2013.42","article-title":"Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study","volume":"108","author":"Capurso","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib123","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/MPA.0000000000002267","article-title":"Metabolic Syndrome Accelerates the Age-Related Increase of Intraductal Papillary Mucinous Neoplasm of the Pancreas","volume":"53","author":"Tanaka","year":"2024","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2024.12.005_bib124","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.amjsurg.2016.10.033","article-title":"Smoking and IPMN malignant progression","volume":"213","author":"Carr","year":"2017","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib125","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s11605-014-2714-y","article-title":"Smoking is not associated with severe dysplasia or invasive carcinoma in resected intraductal papillary mucinous neoplasms","volume":"19","author":"Rezaee","year":"2015","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib126","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/MPA.0000000000000761","article-title":"Smoking Status and the Incidence of Pancreatic Cancer Concomitant With Intraductal Papillary Mucinous Neoplasm","volume":"46","author":"Nakagawa","year":"2017","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.semcancer.2024.12.005_bib127","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000481234","article-title":"Association between the Risk Factors for Pancreatic Ductal Adenocarcinoma and Those for Malignant Intraductal Papillary Mucinous Neoplasm","volume":"93","author":"Kamata","year":"2017","journal-title":"Oncology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib128","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.surg.2013.07.011","article-title":"Obesity increases malignant risk in patients with branch-duct intraductal papillary mucinous neoplasm","volume":"154","author":"Sturm","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.semcancer.2024.12.005_bib129","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MPA.0000000000001027","article-title":"Predictors of Progression Among Low-Risk Intraductal Papillary Mucinous Neoplasms in a Multicenter Surveillance Cohort","volume":"47","author":"Gausman","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2024.12.005_bib130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ueg2.12207","article-title":"International external validation of a stratification tool to identify branch-duct intraductal papillary mucinous neoplasms at lowest risk of progression","volume":"10","author":"Overbeek","year":"2022","journal-title":"U. Eur. Gastroenterol. J."},{"key":"10.1016\/j.semcancer.2024.12.005_bib131","article-title":"Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer","author":"Lauri","year":"2024","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.semcancer.2024.12.005_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061722","article-title":"The Role of Genetic, Metabolic, Inflammatory, and Immunologic Mediators in the Progression of Intraductal Papillary Mucinous Neoplasms to Pancreatic Adenocarcinoma","volume":"15","author":"Shockley","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2024.12.005_bib133","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aaw3145","article-title":"The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice","volume":"364","author":"Engle","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2024.12.005_bib134","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.humpath.2017.03.008","article-title":"SLC2A1\/GLUT1 expression in mural nodules of intraductal papillary mucinous neoplasm of the pancreas","volume":"65","author":"Oda","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR Signaling in Growth, Metabolism, and Disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2024.12.005_bib136","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ags3.12367","article-title":"S6 ribosomal protein phosphorylation is associated with malignancy of intraductal papillary mucinous neoplasm of the pancreas","volume":"4","author":"Hirashita","year":"2020","journal-title":"Ann. Gastroenterol. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib137","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2024.12.005_bib138","first-page":"5489","article-title":"Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin","volume":"43","author":"Magnani","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2024.12.005_bib139","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1002\/pmic.201000827","article-title":"Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases","volume":"11","author":"Yue","year":"2011","journal-title":"Proteomics"},{"key":"10.1016\/j.semcancer.2024.12.005_bib140","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1245\/s10434-012-2809-1","article-title":"CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy","volume":"20","author":"Hartwig","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib141","first-page":"105","article-title":"The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal","volume":"3","author":"Ballehaninna","year":"2012","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10061284","article-title":"A Review of the Diagnosis and Management of Premalignant Pancreatic Cystic Lesions","volume":"10","author":"Keane","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.semcancer.2024.12.005_bib143","article-title":"Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct expression patterns and potential markers of progression","author":"Wang","year":"2024","journal-title":"BioRxiv Prepr. Serv. Biol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib144","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41556-018-0122-3","article-title":"Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism","volume":"20","author":"Patra","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib145","article-title":"Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alteration","author":"Sans","year":"2023","journal-title":"BioRxiv Prepr. Serv. Biol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib146","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1038\/s41467-024-46994-2","article-title":"Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms","volume":"15","author":"Agostini","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2024.12.005_bib147","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade4582","article-title":"Digital spatial profiling of intraductal papillary mucinous neoplasms: Toward a molecular framework for risk stratification","volume":"9","author":"Iyer","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.semcancer.2024.12.005_bib148","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1158\/1078-0432.CCR-10-1561","article-title":"Cyst fluid interleukin-1b (IL1b) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas","volume":"17","author":"Maker","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2024.12.005_bib149","unstructured":"Intraductal Papillary Mucinous Cancer Of The Pancreas - StatPearls - NCBI Bookshelf, (n.d.). \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507779\/\u3009 (accessed January 7, 2021)."},{"key":"10.1016\/j.semcancer.2024.12.005_bib150","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46634-6","article-title":"Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer","volume":"9","author":"Gaiser","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2024.12.005_bib151","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1038\/s41598-022-08527-z","article-title":"Author Correction: Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer","volume":"12","author":"Gaiser","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2024.12.005_bib152","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ijc.33875","article-title":"Noninvasive risk stratification of intraductal papillary mucinous neoplasia with malignant potential by serum apolipoprotein-A2-isoforms","volume":"150","author":"Felix","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2024.12.005_bib153","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2006.01.016","article-title":"Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases","volume":"119","author":"Park","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib154","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2013.08.018","article-title":"A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice","volume":"145","author":"Philip","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib155","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1158\/0008-5472.CAN-04-1177","article-title":"Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2","volume":"64","author":"Ito","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2024.12.005_bib156","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/MPA.0000000000001377","article-title":"Pancreatic Fluid Interleukin-1\u03b2 Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia","volume":"48","author":"Simpson","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2024.12.005_bib157","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2337\/db16-1477","article-title":"Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer","volume":"66","author":"Andersen","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.semcancer.2024.12.005_bib158","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.surg.2020.07.006","article-title":"Diabetes mellitus in intraductal papillary mucinous neoplasms: A systematic review and meta-analysis","volume":"169","author":"Pergolini","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.semcancer.2024.12.005_bib159","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cgh.2020.04.090","article-title":"Diabetes and Weight Loss Are Associated With Malignancies in Patients With Intraductal Papillary Mucinous Neoplasms","volume":"19","author":"Pergolini","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib160","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.pan.2017.08.073","article-title":"Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma","volume":"17","author":"Morales-Oyarvide","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib161","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/MPA.0000000000001103","article-title":"Pancreatic Fat Content Detected by Computed Tomography and Its Significant Relationship With Intraductal Papillary Mucinous Neoplasm","volume":"47","author":"Kashiwagi","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2024.12.005_bib162","doi-asserted-by":"crossref","first-page":"23078","DOI":"10.18632\/oncotarget.25212","article-title":"Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma","volume":"9","author":"Unger","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2024.12.005_bib163","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1021\/acs.jproteome.1c00018","article-title":"Metabolic Characterization of Plasma and Cyst Fluid from Cystic Precursors to Pancreatic Cancer Patients Reveal Metabolic Signatures of Bacterial Infection","volume":"20","author":"Morgell","year":"2021","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.semcancer.2024.12.005_bib164","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1158\/1078-0432.CCR-16-2244","article-title":"Predicting the Grade of Dysplasia of Pancreatic Cystic Neoplasms Using Cyst Fluid DNA Methylation Markers","volume":"23","author":"Hata","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2024.12.005_bib165","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1349-7006.2006.00308.x","article-title":"Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma","volume":"97","author":"Jiang","year":"2006","journal-title":"Cancer Sci."},{"key":"10.1016\/j.semcancer.2024.12.005_bib166","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/sj.onc.1208050","article-title":"Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma","volume":"24","author":"Sato","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2024.12.005_bib167","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/gast.2002.34160","article-title":"Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas","volume":"123","author":"Sato","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib168","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41598-021-04335-z","article-title":"Relevance of gene mutations and methylation to the growth of pancreatic intraductal papillary mucinous neoplasms based on pyrosequencing","volume":"12","author":"Asano","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2024.12.005_bib169","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00432-016-2164-x","article-title":"Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms","volume":"142","author":"Yoshida","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/MPA.0000000000001002","article-title":"Effect of Reprimo Down-regulation on Malignant Transformation of Intraductal Papillary Mucinous Neoplasm","volume":"47","author":"Nakazato","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2024.12.005_bib171","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1245\/s10434-020-08291-2","article-title":"Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN)","volume":"27","author":"Fujiyama","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib172","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/carcin\/24.2.193","article-title":"Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas","volume":"24","author":"House","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2024.12.005_bib173","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/modpathol.2008.157","article-title":"Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas","volume":"21","author":"Hong","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib174","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1158\/1078-0432.CCR-11-1718","article-title":"Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas","volume":"18","author":"Hong","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2024.12.005_bib175","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.semcancer.2024.12.005_bib176","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.semcancer.2024.12.005_bib177","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4161\/cbt.8.4.7338","article-title":"MicroRNA miR-155 is a biomarker of early pancreatic neoplasia","volume":"8","author":"Habbe","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.semcancer.2024.12.005_bib178","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1517\/14712598.2015.1029914","article-title":"Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma","volume":"15","author":"Komatsu","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.semcancer.2024.12.005_bib179","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3892\/ijo.2014.2743","article-title":"Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer","volume":"46","author":"Abue","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib180","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1158\/1940-6207.CAPR-15-0094","article-title":"Plasma microRNAs as novel biomarkers for patients with intraductal papillary mucinous neoplasms of the pancreas","volume":"8","author":"Permuth-Wey","year":"2015","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.semcancer.2024.12.005_bib181","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.canlet.2014.09.029","article-title":"Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions","volume":"356","author":"Wang","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2024.12.005_bib182","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/SLA.0000000000001809","article-title":"MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts","volume":"265","author":"Vila-Navarro","year":"2017","journal-title":"Ann. Surg."},{"key":"10.1016\/j.semcancer.2024.12.005_bib183","doi-asserted-by":"crossref","first-page":"58765","DOI":"10.18632\/oncotarget.17679","article-title":"MicroRNA expression levels as diagnostic biomarkers for intraductal papillary mucinous neoplasm","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2024.12.005_bib184","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12885-018-4006-5","article-title":"An elevated expression of serum exosomal microRNA-191, - 21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker","volume":"18","author":"Goto","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2024.12.005_bib185","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000029","article-title":"Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia","volume":"10","author":"Vila-Navarro","year":"2019","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib186","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12876-020-01287-y","article-title":"Exosomal miRNA signatures of pancreatic lesions","volume":"20","author":"Vicentini","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib187","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.21873\/anticanres.14138","article-title":"Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic Cancer","volume":"40","author":"Sonohara","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.semcancer.2024.12.005_bib188","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4166\/kjg.2011.58.4.190","article-title":"MicroRNA expression pattern in intraductal papillary mucinous neoplasm","volume":"58","author":"Park","year":"2011","journal-title":"Korean J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib189","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22063221","article-title":"MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing","volume":"22","author":"Kuratomi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2024.12.005_bib190","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3892\/ol.2020.12178","article-title":"Circulating extracellular vesicle-encapsulated microRNA as screening biomarkers for intraductal papillary mucinous neoplasm","volume":"20","author":"Sato","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.semcancer.2024.12.005_bib191","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112249","article-title":"Micro-RNA Analysis of Pancreatic Cyst Fluid for Diagnosing Malignant Transformation of Intraductal Papillary Mucinous Neoplasm by Comparing Intraductal Papillary Mucinous Adenoma and Carcinoma","volume":"10","author":"Shirakami","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.semcancer.2024.12.005_bib192","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1158\/1078-0432.CCR-22-2531","article-title":"Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)","volume":"29","author":"Zhang","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2024.12.005_bib193","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000329183","article-title":"Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma","volume":"11","author":"Ryu","year":"2011","journal-title":"Pancreatology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib194","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/MPA.0b013e318243a905","article-title":"MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma","volume":"41","author":"Panarelli","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.semcancer.2024.12.005_bib195","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1158\/1078-0432.CCR-12-0035","article-title":"miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts","volume":"18","author":"Matthaei","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2024.12.005_bib196","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/annonc\/mds513","article-title":"The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms","volume":"24","author":"Caponi","year":"2013","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib197","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1158\/1078-0432.CCR-12-3092","article-title":"MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls","volume":"19","author":"Li","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.semcancer.2024.12.005_bib198","doi-asserted-by":"crossref","first-page":"S750","DOI":"10.1245\/s10434-014-3946-5","article-title":"Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes","volume":"21","author":"Lahat","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib199","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116869","article-title":"A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas","volume":"10","author":"Permuth-Wey","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2024.12.005_bib200","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102369","article-title":"MicroRNAs Deregulated in Intraductal Papillary Mucinous Neoplasm Converge on Actin Cytoskeleton-Related Pathways That Are Maintained in Pancreatic Ductal Adenocarcinoma","volume":"13","author":"Fernandez-Casta\u00f1er","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2024.12.005_bib201","doi-asserted-by":"crossref","first-page":"16170","DOI":"10.1073\/pnas.0703942104","article-title":"Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development","volume":"104","author":"Gironella","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2024.12.005_bib202","first-page":"465","article-title":"Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA","volume":"3","author":"Sarkar","year":"2013","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.semcancer.2024.12.005_bib203","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0378-4347(00)83044-3","article-title":"High-performance liquid chromatographic method for the radiometric determination of [14C] bucromarone in human plasma utilizing non-radiolabeled bucromarone as an internal standard","volume":"487","author":"Everett","year":"1989","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.semcancer.2024.12.005_bib204","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1245\/s10434-012-2252-3","article-title":"MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene","volume":"19","author":"Ohuchida","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249375","article-title":"MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3","volume":"16","author":"Tian","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2024.12.005_bib206","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.yexcr.2017.10.033","article-title":"Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K\/Akt signaling via caveolin-1 and PTEN","volume":"361","author":"Xiong","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.semcancer.2024.12.005_bib207","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1541-7786.MCR-11-0272","article-title":"MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9","volume":"10","author":"Hamada","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.semcancer.2024.12.005_bib208","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.canlet.2014.05.013","article-title":"Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling","volume":"351","author":"Ali","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2024.12.005_bib209","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1158\/1538-7445.AM10-5703","article-title":"Up-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2024.12.005_bib210","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2009.08.065","article-title":"Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer","volume":"137","author":"Weiss","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2024.12.005_bib211","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/mc.22023","article-title":"Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma","volume":"53","author":"Liu","year":"2014","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.semcancer.2024.12.005_bib212","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/1535-7163.MCT-08-0592","article-title":"MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance","volume":"8","author":"Moriyama","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.semcancer.2024.12.005_bib213","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/jcp.30614","article-title":"Differential regulation of miR-21-5p delays wound healing of melanocyte-deprived vitiligo skin by modulating the expression of tumor-suppressors PDCD4 and Maspin","volume":"237","author":"Brahmbhatt","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.semcancer.2024.12.005_bib214","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1582-4934.2008.00510.x","article-title":"MicroRNA and cancer--focus on apoptosis","volume":"13","author":"Wang","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.semcancer.2024.12.005_bib215","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/ijc.25506","article-title":"Micro-RNA-21 regulates TGF-\u03b2-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction","volume":"128","author":"Yao","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2024.12.005_bib216","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41389-020-0227-y","article-title":"MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynamics","volume":"9","author":"Vila-Navarro","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.semcancer.2024.12.005_bib217","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12935-020-01529-9","article-title":"MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value","volume":"20","author":"Wu","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.semcancer.2024.12.005_bib218","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1261\/rna.045757.114","article-title":"MiR-103a-3p targets the 5\u2019 UTR of GPRC5A in pancreatic cells","volume":"20","author":"Zhou","year":"2014","journal-title":"RNA"},{"key":"10.1016\/j.semcancer.2024.12.005_bib219","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12935-018-0643-7","article-title":"LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer","volume":"18","author":"An","year":"2018","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.semcancer.2024.12.005_bib220","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/carcin\/bgq160","article-title":"The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS","volume":"31","author":"Zhao","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2024.12.005_bib221","first-page":"1115","article-title":"miR-216a-mediated upregulation of TSPAN1 contributes to pancreatic cancer progression via transcriptional regulation of ITGA2","volume":"10","author":"Wang","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.semcancer.2024.12.005_bib222","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.bbrc.2016.12.167","article-title":"MiR-216a decreases MALAT1 expression, induces G2\/M arrest and apoptosis in pancreatic cancer cells","volume":"483","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2024.12.005_bib223","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.3892\/or.2014.3478","article-title":"MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2","volume":"32","author":"Wang","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2024.12.005_bib224","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.yexcr.2017.07.039","article-title":"YB-1 expression promotes pancreatic cancer metastasis that is inhibited by microRNA-216a","volume":"359","author":"Lu","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.semcancer.2024.12.005_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2024.11.010","article-title":"Explainable machine learning identifies a polygenic risk score as a key predictor of pancreatic cancer risk in the UK Biobank","author":"Peduzzi","year":"2024","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.semcancer.2024.12.005_bib226","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11123206","article-title":"An Integrative Pancreatic Cancer Risk Prediction Model in the UK Biobank","volume":"11","author":"Ke","year":"2023","journal-title":"Biomedicines"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X24000993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X24000993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T02:54:22Z","timestamp":1740279262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X24000993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":226,"alternative-id":["S1044579X24000993"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2024.12.005","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2024.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}